false 0001124804 0001124804 2021-05-25 2021-05-25

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 25, 2021

 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

 

 

Delaware

001-35547

36-4392754

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(IRS Employer Identification No.)

222 Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654

(Address of Principal Executive Offices) (Zip Code)

Registrant’s Telephone Number, Including Area Code: (800) 334-8534

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol

Name of Each Exchange on which Registered

Common Stock, par value $0.01 per share

MDRX

The Nasdaq Stock Market LLC

(Nasdaq Global Select Market)

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 

 

Item 5.07Submission of Matters to a Vote of Security Holders

At the 2021 Annual Meeting held on May 25, 2021, the stockholders of the Company voted on the following three proposals and cast their votes as described below:

1.The individuals listed below were elected at the 2021 Annual Meeting to serve as directors of the Company until the next annual meeting of stockholders and until their successors are duly elected and qualified.

 

 

For

Against

Abstain

Broker Non-Vote

Elizabeth A. Altman

122,029,817

96,770

23,320

8,581,109

Mara G. Aspinall

116,313,184

5,813,441

23,282

8,581,109

Paul M. Black

121,869,605

250,907

29,395

8,581,109

P. Gregory Garrison

121,883,317

233,753

32,837

8,581,109

Jonathan J. Judge

119,228,528

2,889,164

32,215

8,581,109

Michael A. Klayko

119,563,510

2,553,646

32,751

8,581,109

Dave B. Stevens

117,051,845

5,065,967

32,095

8,581,109

David D. Stevens

121,842,946

271,837

35,124

8,581,109

Carol J. Zierhoffer

122,029,371

96,952

23,584

8,581,109

 

2.A management proposal to ratify the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021, as described in the proxy materials, was approved.

 

For

Against

Abstain

Broker Non-Vote

129,998,496

715,232

17,288

0

 

3.A non-binding, advisory resolution to approve named executive officer compensation, as described in the proxy materials, was approved.

 

For

Against

Abstain

Broker Non-Vote

118,882,299

3,155,088

112,520

8,581,109

 

 

 


 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.

 

 

 

 

Date: May 25, 2021

 

By:

/s/ Eric Jacobson

 

 

 

Eric Jacobson

 

 

 

Senior Vice President and Corporate Secretary

 

 

Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Veradigm Charts.
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Veradigm Charts.